XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities:        
Net income (loss) $ (16,562) $ (5,562) $ 324,117 $ (14,113)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 203 251 850 1,028
Loss on extinguishment of debt   10,170
Noncash lease expense 222 276 928 1,312
Paid-in-kind interest on convertible notes payable   306 1,085 723
Amortization of debt discount   1,250 4,237 2,485
Share-based compensation 1,510 57 294 125
Change in fair value of convertible notes payable derivative liabilities   635 1,358 (1,118)
Change in fair value of contingent consideration liability     (27)
Change in fair value of warrant liability     (363,299)
Changes in operating assets and liabilities:        
Accounts receivable 12 107 53 (28)
Prepaid expenses and other current assets 817 28 (8,301) (62)
Other assets     19 106
Accounts payable 132 (270) 734 (684)
Accrued expenses and other current liabilities 3,091 (120) 5,764 (21)
Operating lease liabilities (182) (283) (953) (798)
Net cash used in operating activities (10,757) (3,325) (22,944) (11,072)
Cash Flows from Investing Activities:        
Purchase of property and equipment (358) (80) (311) (349)
Purchase of investments (219,460) (237,851)  
Proceeds from sale of property and equipment   22  
Proceeds from sale of investments 160,001      
Net cash used in investing activities (59,817) (80) (238,140) (349)
Cash Flows from Financing Activities:        
Proceeds from exercise of stock warrants, net of issuance costs 16,257   140,800  
Payments for Paycheck Protection Program loan (908)      
Proceeds from exercise of common stock options 287   121 7
Proceeds from convertible notes payable issuance and derivative liability   3,200    
Business Combination and PIPE financing, net of issuance costs paid   516,454  
Proceeds from the exercise of stock warrants   124,536  
Proceeds from convertible notes payable issuance and derivative liabilities     3,200 16,803
Proceeds from Paycheck Protection Program loan   908  
Payments for deferred financing costs   (468)  
Repayments on finance lease obligations (49) (54) (247) (201)
Net cash provided by financing activities 15,587 3,146 644,504 16,609
Net decrease in cash and cash equivalents (54,987) (259) 383,420 5,188
Cash and cash equivalents- beginning of the period 389,705 6,285 6,285 1,097
Cash and cash equivalents - end of the period $ 334,718 $ 6,026 $ 389,705 $ 6,285